Is Envista Holdings Corporation (NVST) a Top Ariel Investment Stock to Buy?

Envista Holdings Corporation (NYSE:NVST) is one of the top stocks to buy according to Ariel Investments. On June 11, Barclays reiterated an Overweight rating on Envista Holdings Corporation (NYSE:NVST) but lowered the price target to $32 from $34.

This is Why Envista Holdings Corporation (NVST) is a Top Ariel Investment’s Stock to Buy

According to the research firm, Envista Holdings’ end markets continue to stabilize. Consequently, it tweaked its estimates to reflect the first quarter report. During the quarter, the company delivered growth across all major businesses, driven by customer engagement and new product commercialization. The company’s 9.5% core revenue growth translated into 25% adjusted EBITDA growth and 50% earnings-per-share growth.

Buoyed by impressive first-quarter momentum, Envista Holdings reiterated its full-year guidance, with sales expected to grow between 2% and 4% and adjusted EBITDA between 7% and 13%. Envista Holdings Corp expects full-year adjusted diluted earnings per share to come in between $1.35 and $1.45 a share.

Envista Holdings Corporation (NYSE:NVST) is a global medical technology company that develops, manufactures, and markets dental products and equipment. Spun off from Danaher Corporation, they manage a portfolio of over 30 trusted brands, including Nobel Biocare, Ormco, DEXIS, and Kerr.

While we acknowledge the risk and potential of NVST as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVST and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 9 Best Energy Dividend Stocks to Invest In Now and 10 Best Dividend Aristocrat Stocks To Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1